The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
Woman Seriously Injured in Medford Delivery Truck Accident on Lake Drive MEDFORD, NEW YORK (August…
Tennessee Truck driver Died After Being Hit By Debris From another Vehicle Along Interstate 90…
Pedestrian Thrown Into The Air After Inwood Collision Involving Corvette and Mercedes-Benz INWOOD, MANHATTAN (August…
Ford F-250 Involved in Deadly Hit-And-Run Collision With Cyclist on Jamaica Avenue in Brooklyn BROOKLYN,…
NYPD Investigating Longwood, Bronx Bus Accident That Injured Nearly 20 People by Southern Boulevard and…
Unlicensed Driver Charged After Patchogue Car Accident That Seriously Injured Pedestrian PATCHOGUE, NEW YORK (August…